The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine
Abstract
Abstract: Repeated methamphetamine (METH) administration to animals can result in long‐lasting decreases in brain dopamine (DA) and serotonin (5‐HT) content. Calcitriol, the active metabolite of vitamin D, has potent effects on brain cells, both in vitro and in vivo, including the ability to upregulate trophic factors and protect against various lesions. The present experiments were designed to examine the ability of calcitriol to protect against METH‐induced reductions in striatal and nucleus accumbens levels of DA and 5‐HT. Male Fischer‐344 rats were administered vehicle or calcitriol (1μg/kg, s.c.) once a day for eight consecutive days. After the seventh day of treatment the animals were given METH (5 mg/kg, s.c.) or saline four times in 1 day at 2‐h intervals. Seven days later the striata and accumbens were harvested from the animals for high‐performance liquid chromatography (HPLC) analysis of monoamines and metabolites. In animals treated with vehicle and METH, there were significant reductions in DA, 5‐HT, and their metabolites in both the striatum and accumbens. In animals treated with calcitriol and METH, the magnitude of the METH‐induced reductions in DA, 5‐HT, and metabolites was substantially and significantly attenuated. The calcitriol treatments did not reduce the hyperthermia associated with multiple injections of METH, indicating that the neuroprotective effects of calcitriol are not due to the prevention of increases in body temperature. These results suggest that calcitriol can provide significant protection against the DA‐ and 5‐HT‐depleting effects of neurotoxic doses of METH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The brain chemistry of children with ASD may differ from that of children with developmental delay [142], and as such the response to vitamin D supplement—that may affect brain chemistry [143]—could vary.”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [143]
In the citing paper
“Pre-treatment with calcitriol has been shown to protect rats’ striatum and accumbens from methamphetamine-induced reduction in dopamine and serotonin [143].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [143]
Citations
Cites
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Functional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
Self-citationThe Pharmacological Basis of Therapeutics.
Goodman, L., & Gilman, A. G. (1941) · Anesthesia & Analgesia · doi:10.1213/00000539-194101000-00064 · Cited by 604
Hoffer, B. J., Hoffman, A. F., Bowenkamp, K., Huettl, P. F., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453
Winkler, C., Sauer, H., Lee, C. S., & Björklund, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07206.1996 · Cited by 258
Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats
Wang, J., Wu, J.-N., Cherng, T.-L., Hoffer, B. J., Chen, H.-H., Borlongan, C. V., & Wang, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02450-7 · Cited by 242
Ibi, M., Sawada, H., Nakanishi, M., Kume, T., Katsuki, H., Kaneko, S., Shimohama, S., & AKAIKE, A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00009-0 · Cited by 233
1,25(OH)2 vitamin D3 sites of action in the brain
Stumpf, W. E., & O'Brien, L. P. (1987) · Histochemistry and Cell Biology · doi:10.1007/bf00496810 · Cited by 218
Garcion, E., Sindji, L., Leblondel, G., Brachet, P., & Darcy, F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730859.x · Cited by 213
1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor
Naveilhan, P., Neveu, I., Wion, D., & Brachet, P. (1996) · Neuroreport · doi:10.1097/00001756-199609020-00023 · Cited by 213
Cited by
Sorted by citations
Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.07.001 · Cited by 726
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
de Abreu, D. A. F., Eyles, D. W., & Feron, F. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.023 · Cited by 392
Review: The role of vitamin D in nervous system health and disease
DeLuca, G. C., Kimball, S., Kolasinski, J., Ramagopalan, S. V., & Ebers, G. C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12020 · Cited by 340
Spedding, S. J. (2014) · Nutrients · doi:10.3390/nu6041501 · Cited by 304
Metadata
- Authors
- CASS, W. A., SMITH, M. P., & PETERS, L. E.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- CASS, WAYNE A.
- ORCID
- CASS, WAYNE A.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2006-08
- Volume
- 1074
- Issue
- 1
- Pages
- 261-271
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2087559183
- Cited by
- 149
- References
- 32
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 4 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 14 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 16 · 2013: 10 · 2012: 10
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29da010115-05)
- U.S. Public Health Service
- National Institute on Aging (R01AG017963, AG17963)
- National Institute on Drug Abuse (DA 10115)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- 1,25-dihydroxyvitamin D3, methamphetamine, dopamine depletion, serotonin depletion, neuroprotection, striatum, nucleus accumbens, monoamine metabolites, hyperthermia, neurotoxicity, vitamin D metabolites
- MeSH terms
- Animals, Calcitriol, Corpus Striatum, Dopamine, Drug Interactions, Hyperthermia, Induced, Male, Methamphetamine, Nucleus Accumbens, Rats, Inbred F344, Serotonin, Dopamine Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
